Evidence mapPaperPMID 37474635Full record

ArticleScientific reports2023

A comprehensive risk factor analysis using association rules in people with diabetic kidney disease.

Tadashi Toyama, Miho Shimizu, Taihei Yamaguchi, Hidekazu Kurita, Tetsurou Morita, Megumi Oshima, Shinji Kitajima, Akinori Hara, Norihiko Sakai, Atsushi Hashiba and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Tadashi ToyamaDepartment of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan. t-toyama@staff.kanazawa-u.ac.jp.
Miho ShimizuDepartment of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Taihei YamaguchiLife Science Business Office, Corporate Technology Planning Division, Toshiba Corporation, Tokyo, Japan.
Hidekazu KuritaInsurance Solutions Department, ICT Solutions Division, Toshiba Digital Solutions Corporation, Kawasaki, Japan.
Tetsurou MoritaInsurance Solutions Department, ICT Solutions Division, Toshiba Digital Solutions Corporation, Kawasaki, Japan.
Megumi OshimaDepartment of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Shinji KitajimaDepartment of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Akinori HaraDepartment of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Norihiko SakaiDepartment of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Atsushi HashibaKanazawa Medical Association, Kanazawa, Japan.
Takuzo TakayamaFrontier Science and Social Co-Creation Initiative, Kanazawa University, Kanazawa, Japan.
Atsushi TajimaDepartment of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.
Kengo FuruichiDepartment of Nephrology, Kanazawa Medical University School of Medicine, Uchinada, Japan.
Takashi WadaDepartment of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Yasunori IwataDepartment of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Kanazawa University · JPToshiba (Japan) · JPKanazawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Association rule is a transparent machine learning method expected to share information about risks for chronic kidney disease (CKD) among diabetic patients, but its findings in clinical data are limited. We used the association rule to evaluate the risk for kidney disease in General and Worker diabetic cohorts. The absence of risk factors was examined for association with stable kidney function and worsening kidney function. A confidence value was used as an index of association, and a lift of > 1 was considered significant. Analyses were applied for individuals stratified by KDIGO's (Kidney Disease: Improving Global Outcomes) CKD risk categories. A General cohort of 4935 with a mean age of 66.7 years and a Worker cohort of 2153 with a mean age of 47.8 years were included in the analysis. Good glycemic control was significantly related to stable kidney function in low-risk categories among the General cohort, and in very-high risk categories among the Worker cohort; confidences were 0.82 and 0.77, respectively. Similar results were found with poor glycemic control and worsening kidney function; confidences of HbA1c were 0.41 and 0.27, respectively. Similarly, anemia, obesity, and hypertension showed significant relationships in the low-risk General and very-high risk Worker cohorts. Stratified risk assessment using association rules revealed the importance of the presence or absence of risk factors.

Indexed as

Diabetes MellitusDiabetic NephropathiesHypertensionRenal Insufficiency, ChronicAgedHumansMiddle AgedRisk AssessmentRisk Factors

Identifiers

PMID37474635
PMCPMC10359444
OpenAlexW4384923667

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.